Panretin (Pan-RET-in, alitretinoin) gel, the first TOPICAL treatment for Kaposi's sarcoma

The FDA just approved Panretin (Pan-RET-in, alitretinoin) gel, the first TOPICAL treatment for Kaposi's sarcoma.

Alitretinoin is a form of retinoic acid.

It's applied to skin lesions to inhibit cell growth...it doesn't prevent new lesions or treat systemic disease.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote